John Sculley - Net Worth and Insider Trading
John Sculley Net Worth
The estimated net worth of John Sculley is at least $120 Million dollars as of 2024-11-09. John Sculley is the Director of Zeta Global Holdings Corp and owns about 3,380,328 shares of Zeta Global Holdings Corp (ZETA) stock worth over $120 Million. John Sculley is also the Director of Salarius Pharmaceuticals Inc and owns about 12 shares of Salarius Pharmaceuticals Inc (SLRX) stock worth over $18. Details can be seen in John Sculley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Sculley has not made any transactions after 2021-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Sculley
John Sculley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Sculley owns 7 companies in total, including Kaleido Biosciences Inc (KLDO) , Salarius Pharmaceuticals Inc (SLRX) , and T-Mobile US Inc (TMUS) among others .
Click here to see the complete history of John Sculley’s form 4 insider trades.
Insider Ownership Summary of John Sculley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KLDO | Kaleido Biosciences Inc | 2019-02-27 | director |
| SLRX | Salarius Pharmaceuticals Inc | 2016-03-21 | director |
| TMUS | T-Mobile US Inc | 2004-07-28 | director |
 | | 2022-07-13 | director |
| | 2021-03-10 | director |
| | 2021-06-14 | director |
| | 2021-03-10 | director |
John Sculley Latest Holdings Summary
John Sculley currently owns a total of 2 stocks. Among these stocks, John Sculley owns 3,380,328 shares of Zeta Global Holdings Corp (ZETA) as of June 14, 2021, with a value of $120 Million and a weighting of 100%. John Sculley also owns 12 shares of Salarius Pharmaceuticals Inc (SLRX) as of March 21, 2016, with a value of $18 and a weighting of 0%.
Latest Holdings of John Sculley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZETA | Zeta Global Holdings Corp | 2021-06-14 | 3,380,328 | 35.58 | 120,272,070 |
| SLRX | Salarius Pharmaceuticals Inc | 2016-03-21 | 12 | 1.50 | 18 |
Holding Weightings of John Sculley
John Sculley Form 4 Trading Tracker
According to the SEC Form 4 filings, John Sculley has made a total of 1 transactions in Zeta Global Holdings Corp (ZETA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Zeta Global Holdings Corp is the sale of 261,969 shares on June 14, 2021, which brought John Sculley around $3 Million.
According to the SEC Form 4 filings, John Sculley has made a total of 0 transactions in Salarius Pharmaceuticals Inc (SLRX) over the past 5 years. The most-recent trade in Salarius Pharmaceuticals Inc is the acquisition of 1 shares on March 21, 2016, which cost John Sculley around $56,131.
Insider Trading History of John Sculley
- 1
John Sculley Trading Performance
GuruFocus tracks the stock performance after each of John Sculley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Sculley is -4.84%. GuruFocus also compares John Sculley's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Sculley within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Sculley's insider trading performs compared to the benchmark.
Performance of John Sculley
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.69 | | | | | |
| Relative Return to S&P 500(%) | 3.75 | | | | | |
John Sculley Ownership Network
Ownership Network List of John Sculley
Ownership Network Relation of John Sculley
John Sculley Owned Company Details
What does Kaleido Biosciences Inc do?
Who are the key executives at Kaleido Biosciences Inc?
John Sculley is the director of Kaleido Biosciences Inc. Other key executives at Kaleido Biosciences Inc include Chief Medical Officer Alison S Long , Chief Scientific Officer Van Hylckama Vlieg Johan , and director & Chief Executive Officer Daniel L Menichella .
Kaleido Biosciences Inc (KLDO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Kaleido Biosciences Inc (KLDO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kaleido Biosciences Inc (KLDO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Kaleido Biosciences Inc (KLDO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kaleido Biosciences Inc Insider Transactions
John Sculley Mailing Address
Above is the net worth, insider trading, and ownership report for John Sculley. You might contact John Sculley via mailing address: C/o Kaleido Biosciences, Inc., 65 Hayden Avenue, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
